Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12834)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 14, 2019 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Fung BM, Lindor KD, Tabibian JH. Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies. World J Gastroenterol 2019; 25(6): 659-671 [PMID: 30783370 DOI: 10.3748/wjg.v25.i6.659] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i6/659.htm |
| Number | Citing Articles |
| 1 |
Teresa Brevini, Olivia C. Tysoe, Fotios Sampaziotis. Tissue engineering of the biliary tract and modelling of cholestatic disorders. Journal of Hepatology 2020; 73(4): 918 doi: 10.1016/j.jhep.2020.05.049
|
| 2 |
Brian M. Fung, James H. Tabibian. Primary sclerosing cholangitis-associated cholangiocarcinoma: special considerations and best practices. Expert Review of Gastroenterology & Hepatology 2021; 15(5): 487 doi: 10.1080/17474124.2021.1900732
|
| 3 |
Alexander Strick, Hans Busch, Klaus Friedhoff. Gallenblasenmetastase eines malignen Melanoms. DMW - Deutsche Medizinische Wochenschrift 2022; 147(19): 1277 doi: 10.1055/a-1918-5473
|
| 4 |
Martina Taborelli, Michele Sozzi, Stefania Del Zotto, Federica Toffolutti, Marcella Montico, Loris Zanier, Diego Serraino, Jeffrey S. Chang. Risk of intestinal and extra-intestinal cancers in patients with inflammatory bowel diseases: A population-based cohort study in northeastern Italy. PLOS ONE 2020; 15(6): e0235142 doi: 10.1371/journal.pone.0235142
|
| 5 |
Lu Jiang, Peter Stärkel, Jian-Gao Fan, Derrick Eugene Fouts, Petra Bacher, Bernd Schnabl. The gut mycobiome: a novel player in chronic liver diseases. Journal of Gastroenterology 2021; 56(1): 1 doi: 10.1007/s00535-020-01740-5
|
| 6 |
Domenico Alvaro, Cesare Hassan, Vincenzo Cardinale, Guido Carpino, Luca Fabris, Enrico Gringeri, Vincenza Granata, Massimiliano Mutignani, Helen Morement, Felice Giuliante, Alfredo Guglielmi, Lorenzo Ridola, Marco Marzioni, Gianluca Grazi, Maria Guido, Emilio Di Giulio, Giuseppe Tonini, Francesco Pantano, Rosanna Venere, Maria Consiglia Bragazzi, Francesca Biancanello, Jessica Faccioli, Aurora Giannetti, Marcello Cintolo, Michela Di Giunta, Martina Gambato, Alberto Lasagni, Francesco Izzo, Antonio Avallone, Jesus Banales, Massimo Rossi, Carlo Catalano, Andrea Laghi, Giulia D'amati, Maria Grazia Mancino, Lorenzo Ridola. Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging. Digestive and Liver Disease 2020; 52(11): 1282 doi: 10.1016/j.dld.2020.06.045
|
| 7 |
Sarah Kemme, Cara L. Mack. Pediatric Autoimmune Liver Diseases. Pediatric Clinics of North America 2021; 68(6): 1293 doi: 10.1016/j.pcl.2021.07.006
|
| 8 |
Sohini Das, Manoj Job, Thomas Kodiatte, Ramya Iyadurai. Atypical presentation of intrahepatic cholangiocarcinoma---Fever and ascites in a postpartum lady. Journal of Family Medicine and Primary Care 2019; 8(11): 3748 doi: 10.4103/jfmpc.jfmpc_748_19
|
| 9 |
Johanna Eliasson, Bobby Lo, Christoph Schramm, Olivier Chazouilleres, Trine Folseraas, Ulrich Beuers, Henriette Ytting. Survey uncovering variations in the management of primary sclerosing cholangitis across Europe. JHEP Reports 2022; 4(11): 100553 doi: 10.1016/j.jhepr.2022.100553
|
| 10 |
Michael Bitzer, Sabrina Groß, Jörg Albert, Susanne Blödt, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Markus Follmann, Paul Freudenberger, Cihan Gani, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, David Krug, Christian La Fougère, Hauke Lang, Thomas Langer, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Monika Nothacker, Johann Ockenga, Karl Oldhafer, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Ulrike Ritterbusch, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans Jürgen Schlitt, Irene Schmid, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Nadine Steubesand, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Reina Tholen, Jörg Trojan, Ingo van Thiel, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek. S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Langversion 4.0. Zeitschrift für Gastroenterologie 2024; 62(01): e67 doi: 10.1055/a-2189-6353
|
| 11 |
Dominic Staudenmann, Mark Bonnichsen, Payal Saxena, Arthur John Kaffes. Endoscopic Evaluation of Indeterminate Biliary Strictures: a Review. Current Treatment Options in Gastroenterology 2021; 19(2): 308 doi: 10.1007/s11938-021-00339-w
|
| 12 |
Alireza Beheshti-Maal, Atena Tamimi, Shahrokh Iravani, Arash Memarnejadian, Majid Sorouri, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali, Nikoo Hossein Khannazer, Massoud Vosough. PSC associated inflammatory bowel disease: a distinct entity. Expert Review of Gastroenterology & Hepatology 2022; 16(2): 129 doi: 10.1080/17474124.2022.2031979
|
| 13 |
D. Bel Haj Yahia, M. Bel Hadj Yahya, I. Chelly, R. Ksantini, M. Jouini, M.J. Kacem. 21 years of evolution of primary hepatic neuroendocrine neoplasm in a patient with primary sclerosing cholangitis: A case report. International Journal of Surgery Case Reports 2023; 106: 108205 doi: 10.1016/j.ijscr.2023.108205
|
| 14 |
David M. Chascsa, Keith D. Lindor. Cancer risk, screening and surveillance in primary sclerosing cholangitis. Minerva Gastroenterologica e Dietologica 2019; 65(3) doi: 10.23736/S1121-421X.19.02586-8
|
| 15 |
Brian M. Fung, James H. Tabibian. Cholangiocarcinoma in patients with primary sclerosing cholangitis. Current Opinion in Gastroenterology 2020; 36(2): 77 doi: 10.1097/MOG.0000000000000616
|
| 16 |
Mohammad Mawardi, Abduljaleel Alalwan, Hind Fallatah, Faisal Abaalkhail, Mohammed Hasosah, Mohammad Shagrani, MohammedY Alghamdi, AbdullahS Alghamdi. Cholestatic liver disease: Practice guidelines from the Saudi Association for the Study of Liver diseases and Transplantation. Saudi Journal of Gastroenterology 2021; 27(7): 1 doi: 10.4103/sjg.sjg_112_21
|
| 17 |
Atit Silsirivanit, Chatchai Phoomak, Sopit Wongkham. Diagnosis and Management of Cholangiocarcinoma. 2021; : 527 doi: 10.1007/978-3-030-70936-5_25
|
| 18 |
S. Franssen, D. M. de Jong, L. M. J. W. van Driel, B. Groot Koerkamp. Diagnosis and Management of Cholangiocarcinoma. 2021; : 229 doi: 10.1007/978-3-030-70936-5_9
|
| 19 |
Mario Altieri, Olivier Sérée, Thierry Lobbedez, Philippe Segol, Armand Abergel, Xavier Blaizot, Olivier Boillot, Karim Boudjema, Audrey Coilly, Filomena Conti, Olivier Chazouillères, Maryline Debette-Gratien, Sébastien Dharancy, François Durand, Christophe Duvoux, Claire Francoz, Jean Gugenheim, Jean Hardwigsen, Pauline Houssel-Debry, Nassim Kamar, Marianne Latournerie, Pascal Lebray, Vincent Leroy, Martine Neau-Cransac, Georges-Philippe Pageaux, Sylvie Radenne, Ephrem Salamé, Faouzi Saliba, Didier Samuel, Claire Vanlemmens, Camille Besch, Guy Launoy, Jérôme Dumortier. Risk factors of de novo malignancies after liver transplantation: a French national study on 11004 adult patients. Clinics and Research in Hepatology and Gastroenterology 2021; 45(4): 101514 doi: 10.1016/j.clinre.2020.07.019
|
| 20 |
Francesca Saffioti, Vasileios K Mavroeidis. Review of incidence and outcomes of treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis. World Journal of Gastrointestinal Oncology 2021; 13(10): 1336-1366 doi: 10.4251/wjgo.v13.i10.1336
|
| 21 |
Nelli Sjöblom, Sonja Boyd, Hannu Kautiainen, Johanna Arola, Martti Färkkilä. Novel histological scoring for predicting disease outcome in primary sclerosing cholangitis. Histopathology 2022; 81(2): 192 doi: 10.1111/his.14677
|
| 22 |
Anita Nguyen, Babak Torabi Sagvand, Madeline Alizadeh, Cydney Nguyen, William Scott, Erik C. von Rosenvinge. Primary sclerosing cholangitis and pancreatic cancer: A retrospective cohort study of United States veterans. Frontiers in Gastroenterology 2023; 1 doi: 10.3389/fgstr.2022.1076788
|
| 23 |
Dong He, Wen Zeng, Yi Wang, Yifan Xing, Kang Xiong, Nan Su, Chong Zhang, Yuan Lu, Xinhui Xing. Isolation and characterization of novel peptides from fermented products of Lactobacillus for ulcerative colitis prevention and treatment. Food Science and Human Wellness 2022; 11(6): 1464 doi: 10.1016/j.fshw.2022.06.003
|
| 24 |
Marlone Cunha-Silva, Eloy Vianey Carvalho de França, Clauber Teles Veiga, Raquel Dias Greca, Priscilla Brito Sena de Moraes, Daniel Ferraz de Campos Mazo, Elaine Cristina de Ataíde, Simone Reges Perales, Leonardo Trevizan Monici, Tiago Sevá-Pereira. 15-Year progression to liver cancer in the lack of treatment for lysosomal acid lipase deficiency: A case report. Medicine 2022; 101(35): e30315 doi: 10.1097/MD.0000000000030315
|
| 25 |
Kazuma Daiku, Kazuto Fukuda, Osakuni Morimoto, Daisuke Takiuchi, Hiromi Shimakoshi, Tadashi Kegasawa, Yoshitaka Yamaguchi, Sachiyo Kogita, Yoshiyuki Sawai, Masanori Nakahara, Takumi Igura, Kunitaka Shibata, Yasuharu Imai. Primary adenosquamous carcinoma of the liver detected during cancer surveillance in a patient with primary sclerosing cholangitis. Clinical Journal of Gastroenterology 2020; 13(6): 1273 doi: 10.1007/s12328-020-01204-6
|
| 26 |
Dustin E. Bosch, Yoh Zen, Sarag A. Boukhar, Yongjun Liu, Lin Cheng, Matthew M. Yeh. Hepatocellular carcinoma in primary sclerosing cholangitis and primary biliary cholangitis: a clinical and pathological study in an uncommon but emerging setting. Virchows Archiv 2021; 479(6): 1131 doi: 10.1007/s00428-021-03183-6
|
| 27 |
Rohit Das, Harkirat Singh, Adam Slivka. Gastrointestinal and Pancreatico-Biliary Diseases: Advanced Diagnostic and Therapeutic Endoscopy. 2020; : 1 doi: 10.1007/978-3-030-29964-4_80-1
|
| 28 |
Lei Huang. 2020 International Conference on Applications and Techniques in Cyber Intelligence. Advances in Intelligent Systems and Computing 2021; 1244: 180 doi: 10.1007/978-3-030-53980-1_27
|
| 29 |
Rohit Das, Harkirat Singh, Adam Slivka. Gastrointestinal and Pancreatico-Biliary Diseases: Advanced Diagnostic and Therapeutic Endoscopy. 2022; : 1381 doi: 10.1007/978-3-030-56993-8_80
|
| 30 |
Erik Lundqvist, Ida Hed Myrberg, Sol Erika Boman, Deborah Saraste, Caroline E. Weibull, Kalle Landerholm, Staffan Haapaniemi, Anna Martling, Pär Myrelid, Caroline Nordenvall. Autoimmune and Metabolic Diseases and the Risk of Early-Onset Colorectal Cancer, a Nationwide Nested Case–Control Study. Cancers 2023; 15(3): 688 doi: 10.3390/cancers15030688
|
| 31 |
Haonan Zhang, Yulu Shi, Chanchan Lin, Chengcheng He, Shanping Wang, Qingyuan Li, Yan Sun, Mingsong Li. Overcoming cancer risk in inflammatory bowel disease: new insights into preventive strategies and pathogenesis mechanisms including interactions of immune cells, cancer signaling pathways, and gut microbiota. Frontiers in Immunology 2024; 14 doi: 10.3389/fimmu.2023.1338918
|
| 32 |
Juan E. Corral, Kristopher P. Croome, Andrew P. Keaveny, Bhaumik Brahmbhatt, Paul T. Kröner, Karn Wijarnpreecha, Rohan M. Goswami, Massimo Raimondo, Michael B. Wallace, Yan Bi, Omar Y. Mousa. A 3-Decade Analysis of Pancreatic Adenocarcinoma After Solid Organ Transplant. Pancreas 2021; 50(1): 54 doi: 10.1097/MPA.0000000000001722
|
| 33 |
Silja Steinmann, Ida Schregel, Christoph Schramm. Autoimmune Lebererkrankungen – ein Update (Teil 1). Gastroenterologie up2date 2022; 18(03): 225 doi: 10.1055/a-1364-8489
|
| 34 |
Ahmad Hassan Ali, Elizabeth J. Carey. Diagnosis and Management of Cholangiocarcinoma. 2021; : 435 doi: 10.1007/978-3-030-70936-5_20
|
| 35 |
Brigida Barberio, Davide Massimi, Nora Cazzagon, Fabiana Zingone, Alexander C. Ford, Edoardo V. Savarino. Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Gastroenterology 2021; 161(6): 1865 doi: 10.1053/j.gastro.2021.08.032
|
| 36 |
Katy L. Lawson, Hanlin L. Wang. Primary Sclerosing Cholangitis, Small Duct Primary Sclerosing Cholangitis, IgG4-Related Sclerosing Cholangitis, and Ischemic Cholangiopathy. Surgical Pathology Clinics 2023; 16(3): 533 doi: 10.1016/j.path.2023.04.008
|
| 37 |
Stanisław Rządkowski, Agnieszka Chmielińska, Marek Pacholczyk, Beata Łągiewska. Colonoscopy Surveillance in Liver Transplant Recipients for Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease. Transplantation Proceedings 2020; 52(8): 2484 doi: 10.1016/j.transproceed.2020.01.116
|
| 38 |
M. Bitzer, S. Voesch, J. Albert, P. Bartenstein, W. Bechstein, S. Blödt, T. Brunner, F. Dombrowski, M. Evert, M. Follmann, C. La Fougère, P. Freudenberger, A. Geier, E. Gkika, M. Götz, E. Hammes, T. Helmberger, R. T. Hoffmann, W. P. Hofmann, P. Huppert, A. Kautz, G. Knötgen, J. Körber, D. Krug, F. Lammert, H. Lang, T. Langer, P. Lenz, A. Mahnken, A. Meining, O. Micke, S. Nadalin, H. P. Nguyen, J. Ockenga, K. Oldhafer, P. Paprottka, K. Paradies, P. Pereira, T. Persigehl, M. Plauth, R. Plentz, J. Pohl, J. Riemer, P. Reimer, J. Ringwald, U. Ritterbusch, E. Roeb, B. Schellhaas, P. Schirmacher, I. Schmid, A. Schuler, D. von Schweinitz, D. Seehofer, M. Sinn, A. Stein, A. Stengel, N. Steubesand, C. Stoll, A. Tannapfel, A. Taubert, J. Trojan, I. van Thiel, R. Tholen, A. Vogel, T. Vogl, H. Vorwerk, F. Wacker, O. Waidmann, H. Wedemeyer, H. Wege, D. Wildner, C. Wittekind, M. A. Wörns, P. Galle, N. Malek. S3-Leitlinie – Diagnostik und Therapie biliärer Karzinome. Zeitschrift für Gastroenterologie 2022; 60(02): e186 doi: 10.1055/a-1589-7854
|
| 39 |
Agnes Wittek, Babett Steglich, Christian Casar, Oliver Seiz, Philipp Huber, Hanno Ehlken, Dominik Reher, Sandra Wende, Tanja Bedke, Jan Kempski, Marius Böttcher, Corinna Bang, Louise Thingholm, Till Krech, Ansgar W Lohse, Guido Sauter, Thomas Rösch, Andre Franke, Christoph Schramm, Nicola Gagliani, Penelope Pelczar, Samuel Huber. A Gradient of Intestinal Inflammation in Primary Sclerosing Cholangitis. Inflammatory Bowel Diseases 2023; doi: 10.1093/ibd/izad137
|
| 40 |
Fiona Hand, Emir Hoti. Contemporary role of liver transplantation for the treatment of cholangiocarcinoma. Expert Review of Gastroenterology & Hepatology 2020; 14(6): 475 doi: 10.1080/17474124.2020.1765771
|
| 41 |
Patrick F. van Rheenen. Managing abnormal liver tests in children with inflammatory bowel disease. Current Opinion in Pediatrics 2021; 33(5): 521 doi: 10.1097/MOP.0000000000001045
|
| 42 |
Vitantonio GUGLIELMI, Pietro GIORGIO, Vito GUERRA, Anna SONNANTE, Massimo TUTINO, Rossella DONGHIA, Antonio PISANI. Prognostic value of perinuclear antineutrophil cytoplasmic antibodies in subjects with primary sclerosing cholangitis. Minerva Medica 2022; 113(3) doi: 10.23736/S0026-4806.20.06604-5
|
| 43 |
Morten D. Jensen, Peter Jepsen, Hendrik Vilstrup, Lisbet Grønbæk. Increased Cancer Risk in Autoimmune Hepatitis: A Danish Nationwide Cohort Study. American Journal of Gastroenterology 2022; 117(1): 129 doi: 10.14309/ajg.0000000000001525
|
| 44 |
Hoon Jai Chun, Seun Ja Park, Yun Jeong Lim, Si Young Song. Gastrointestinal Cancer. 2023; : 393 doi: 10.1007/978-981-99-0815-8_55
|
| 45 |
Gabriel Mosquera-Klinger, Nathalie Yepes Madrid, Jhon Jaime Carvajal Gutiérrez. Enfermedad de Crohn con compromiso extenso y manifestaciones extradigestivas inusuales: a propósito de un caso . Revista colombiana de Gastroenterología 2021; 36(Supl. 1): 85 doi: 10.22516/25007440.605
|
| 46 |
Gautham Appanna, Yiannis Kallis. An update on the management of cholestatic liver diseases. Clinical Medicine 2020; 20(5): 513 doi: 10.7861/clinmed.2020-0697
|
| 47 |
Taranika Sarkar Das, Kimberly Ho, Jahnavi Udaikumar, Bryan Chen, Olivia Delau, Aasma Shaukat, Ira Jacobson, Raiya Sarwar. Risk of colorectal cancer in patients with primary sclerosing cholangitis and concomitant inflammatory bowel disease compared with primary sclerosing cholangitis only. Hepatology Research 2024; doi: 10.1111/hepr.14029
|
| 48 |
Karoly Viragh, Maitraya Patel, Shaden Mohammad, Monica Deshmukh, Anokh Pahwa. Diagnosis and Management of Cholangiocarcinoma. 2021; : 179 doi: 10.1007/978-3-030-70936-5_7
|
| 49 |
Zhen-Jiao Li, Hong-Zhong Gou, Yu-Lin Zhang, Xiao-Jing Song, Lei Zhang. Role of intestinal flora in primary sclerosing cholangitis and its potential therapeutic value. World Journal of Gastroenterology 2022; 28(44): 6213-6229 doi: 10.3748/wjg.v28.i44.6213
|
| 50 |
Alexander Ney, Daniel C. Osei‐Bordom, Andres Garcia‐Sampedro, Pilar Acedo, Giuseppe K. Fusai, Martyn Stott, Phillip Hopley, Chandni Patel, Lucy Oldfield, William Greenhalf, Eithne Costello, Stephen P. Pereira. Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e. 2024; : 291 doi: 10.1002/9781119756422.ch17
|
| 51 |
Michael Trauner, Chuhan Chung, Kate Sterling, Xiangyu Liu, Xiaomin Lu, Jun Xu, Clare Tempany-Afdhal, Zachary D. Goodman, Martti Färkkilä, Atsushi Tanaka, Palak Trivedi, Kris V. Kowdley, Christopher L. Bowlus, Cynthia Levy, Robert P. Myers. PRIMIS: design of a pivotal, randomized, phase 3 study evaluating the safety and efficacy of the nonsteroidal farnesoid X receptor agonist cilofexor in noncirrhotic patients with primary sclerosing cholangitis. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02653-2
|
| 52 |
Alexander Strick, Hans Busch, Klaus Friedhoff. Gallenblasenmetastase eines malignen Melanoms. TumorDiagnostik & Therapie 2024; 45(01): 40 doi: 10.1055/a-2238-5283
|
| 53 |
Evangelos Koustas, Eleni-Myrto Trifylli, Panagiotis Sarantis, Athanasios G Papavassiliou, Michalis V Karamouzis. Role of autophagy in cholangiocarcinoma: An autophagy-based treatment strategy. World Journal of Gastrointestinal Oncology 2021; 13(10): 1229-1243 doi: 10.4251/wjgo.v13.i10.1229
|
| 54 |
Hanlai Zhang, Yonghong Gao, Liqin Wang, Li Tian, Na An, Xinyu Yang, Xinye Li, Chao Tian, Mengchen Yuan, Xingjiang Xiong, Nian Liu, Hongcai Shang, Yanwei Xing. Does heart failure increase the risk of incident cancer? A meta-analysis and systematic review. Heart Failure Reviews 2020; 25(6): 949 doi: 10.1007/s10741-019-09876-0
|
| 55 |
Xiaohui Wang, Ting Fu, Junqiao Wang, Changyuan Wang, Kexin Liu, Jingjing Wu, Huijun Sun, Xiaodong Ma, Pengyuan Sun, Qiang Meng. Hepatoprotection of yangonin against hepatic fibrosis in mice via farnesoid X receptor activation. International Immunopharmacology 2019; 75: 105833 doi: 10.1016/j.intimp.2019.105833
|
| 56 |
Ayesha Shah, Graeme A. Macdonald, Mark Morrison, Gerald Holtmann. Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework. American Journal of Gastroenterology 2020; 115(6): 814 doi: 10.14309/ajg.0000000000000604
|
| 57 |
Taylor D. Ellington, Behnoosh Momin, Reda J. Wilson, S. Jane Henley, Manxia Wu, A. Blythe Ryerson. Incidence and Mortality of Cancers of the Biliary Tract, Gallbladder, and Liver by Sex, Age, Race/Ethnicity, and Stage at Diagnosis: United States, 2013 to 2017. Cancer Epidemiology, Biomarkers & Prevention 2021; 30(9): 1607 doi: 10.1158/1055-9965.EPI-21-0265
|
| 58 |
Florian Rennebaum, Claudia Demmig, Hartmut H. Schmidt, Richard Vollenberg, Phil-Robin Tepasse, Jonel Trebicka, Wenyi Gu, Hansjoerg Ullerich, Iyad Kabar, Friederike Cordes. Elevated Liver Fibrosis Progression in Isolated PSC Patients and Increased Malignancy Risk in a PSC-IBD Cohort: A Retrospective Study. International Journal of Molecular Sciences 2023; 24(20): 15431 doi: 10.3390/ijms242015431
|
| 59 |
Sabrina Groß, Michael Bitzer, Jörg Albert, Susanne Blödt, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Markus Follmann, Paul Freudenberger, Cihan Gani, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, David Krug, Christian La Fougère, Hauke Lang, Thomas Langer, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Monika Nothacker, Johann Ockenga, Karl Oldhafer, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Ulrike Ritterbusch, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans J. Schlitt, Irene Schmid, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Nadine Steubesand, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Reina Tholen, Jörg Trojan, Ingo van Thiel, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek. S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Langversion 4.0. Zeitschrift für Gastroenterologie 2024; 62(02): e213 doi: 10.1055/a-2189-8567
|
| 60 |
A.V. Nikitin, G.V. Volynets, T.A. Skvortsova, M.S. Kapranova. Extraintestinal manifestations of inflammatory bowel disease. Dokazatel'naya gastroenterologiya 2023; 12(1): 93 doi: 10.17116/dokgastro20231201193
|
| 61 |
Ron Pery, Rory L Smoot, Cornelius A Thiels, Sean P Cleary, Robert A Vierkant, Sumera I Ilyas, Gregory J Gores, David M Nagorney. Hepatobiliary and pancreatic resection for cholangiocarcinoma in patients with primary sclerosing cholangitis. British Journal of Surgery 2022; 109(11): 1032 doi: 10.1093/bjs/znac229
|
| 62 |
Rebecca Little, Eytan Wine, Binita M Kamath, Anne M Griffiths, Amanda Ricciuto. Gut microbiome in primary sclerosing cholangitis: A review. World Journal of Gastroenterology 2020; 26(21): 2768-2780 doi: 10.3748/wjg.v26.i21.2768
|
| 63 |
Alphonse E. Sirica, Mario Strazzabosco, Massimiliano Cadamuro. Mechanisms and Therapy of Liver Cancer. Advances in Cancer Research 2021; 149: 321 doi: 10.1016/bs.acr.2020.10.005
|
| 64 |
Silvia Cagnin, James H. Tabibian, Luca Fabris. Diagnosis and Management of Cholangiocarcinoma. 2021; : 251 doi: 10.1007/978-3-030-70936-5_10
|
| 65 |
Roongruedee Chaiteerakij. Diagnosis and Management of Cholangiocarcinoma. 2021; : 137 doi: 10.1007/978-3-030-70936-5_5
|
| 66 |
Zuzanna Lukasik, Dirk Elewaut, Koen Venken. MAIT Cells Come to the Rescue in Cancer Immunotherapy?. Cancers 2020; 12(2): 413 doi: 10.3390/cancers12020413
|
| 67 |
Itzel Medina-Andrade, Jonadab E. Olguín, Tonathiu Rodríguez, Luis I. Terrazas. Immunotherapy in Resistant Cancer: From the Lab Bench Work to Its Clinical Perspectives. 2021; : 103 doi: 10.1016/B978-0-12-822028-3.00003-0
|
| 68 |
Sarah Poetter-Lang, Alina Messner, Nina Bastati, Kristina I. Ringe, Maxime Ronot, Sudhakar K. Venkatesh, Raphael Ambros, Antonia Kristic, Aida Korajac, Gregor Dovjak, Martin Zalaudek, Jacqueline. C. Hodge, Christoph Schramm, Emina Halilbasic, Michael Trauner, Ahmed Ba-Ssalamah. Diagnosis of functional strictures in patients with primary sclerosing cholangitis using hepatobiliary contrast-enhanced MRI: a proof-of-concept study. European Radiology 2023; 33(12): 9022 doi: 10.1007/s00330-023-09915-3
|
| 69 |
Vinay K. Kapoor. A Pictorial Treatise on Gall Bladder Cancer. 2021; : 35 doi: 10.1007/978-981-15-5289-2_4
|
| 70 |
Viviana Laredo, Sandra García-Mateo, Samuel J. Martínez-Domínguez, Julia López de la Cruz, Carla J. Gargallo-Puyuelo, Fernando Gomollón. Risk of Cancer in Patients with Inflammatory Bowel Diseases and Keys for Patient Management. Cancers 2023; 15(3): 871 doi: 10.3390/cancers15030871
|
| 71 |
Michael Bitzer, Sabrina Groß, Jörg Albert, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, Achim Kautz, David Krug, Christian La Fougère, Hauke Lang, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Johann Ockenga, Karl Oldhafer, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Ulrike Ritterbusch, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans Jürgen Schlitt, Irene Schmid, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Reina Tholen, Jörg Trojan, Ingo van Thiel, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek. S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Langversion. Zeitschrift für Gastroenterologie 2023; 61(04): e92 doi: 10.1055/a-2026-1240
|